These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 26757190)

  • 1. Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment.
    Oulhaj A; Jernerén F; Refsum H; Smith AD; de Jager CA
    J Alzheimers Dis; 2016; 50(2):547-57. PubMed ID: 26757190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
    de Jager CA; Oulhaj A; Jacoby R; Refsum H; Smith AD
    Int J Geriatr Psychiatry; 2012 Jun; 27(6):592-600. PubMed ID: 21780182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized placebo-controlled trial of using B vitamins to prevent cognitive decline in older mild cognitive impairment patients.
    Kwok T; Wu Y; Lee J; Lee R; Yung CY; Choi G; Lee V; Harrison J; Lam L; Mok V
    Clin Nutr; 2020 Aug; 39(8):2399-2405. PubMed ID: 31787369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase 1, B Vitamins Supplementation, and Mild Cognitive Impairment.
    Perła-Kaján J; Włoczkowska O; Zioła-Frankowska A; Frankowski M; Smith AD; de Jager CA; Refsum H; Jakubowski H
    J Alzheimers Dis; 2021; 81(3):1211-1229. PubMed ID: 33935094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of B Vitamins and Their Interactions with Aspirin in Improving Cognitive Functioning in Older People with Mild Cognitive Impairment: Pooled Post-Hoc Analyses of Two Randomized Trials.
    Wu Y; Smith AD; Refsum H; Kwok T
    J Nutr Health Aging; 2021; 25(10):1154-1160. PubMed ID: 34866142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial.
    Jernerén F; Elshorbagy AK; Oulhaj A; Smith SM; Refsum H; Smith AD
    Am J Clin Nutr; 2015 Jul; 102(1):215-21. PubMed ID: 25877495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer's Disease: The OmegAD Study.
    Jernerén F; Cederholm T; Refsum H; Smith AD; Turner C; Palmblad J; Eriksdotter M; Hjorth E; Faxen-Irving G; Wahlund LO; Schultzberg M; Basun H; Freund-Levi Y
    J Alzheimers Dis; 2019; 69(1):189-197. PubMed ID: 30958356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of long-term nutraceutical and dietary supplement use on cognition in the elderly: a 10-year systematic review of randomised controlled trials.
    D'Cunha NM; Georgousopoulou EN; Dadigamuwage L; Kellett J; Panagiotakos DB; Thomas J; McKune AJ; Mellor DD; Naumovski N
    Br J Nutr; 2018 Feb; 119(3):280-298. PubMed ID: 29310724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
    Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
    Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of a 6-Month High Dose Omega-3 and Omega-6 Polyunsaturated Fatty Acids and Antioxidant Vitamins Supplementation on Cognitive Function and Functional Capacity in Older Adults with Mild Cognitive Impairment.
    Stavrinou PS; Andreou E; Aphamis G; Pantzaris M; Ioannou M; Patrikios IS; Giannaki CD
    Nutrients; 2020 Jan; 12(2):. PubMed ID: 31991898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DHA status influences effects of B-vitamin supplementation on cognitive ageing: a post-hoc analysis of the B-proof trial.
    van Soest APM; van de Rest O; Witkamp RF; Cederholm T; de Groot LCPGM
    Eur J Nutr; 2022 Oct; 61(7):3731-3739. PubMed ID: 35704085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between intake of B vitamins and cognitive function in elderly Koreans with cognitive impairment.
    Kim H; Kim G; Jang W; Kim SY; Chang N
    Nutr J; 2014 Dec; 13(1):118. PubMed ID: 25516359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
    Smith AD; Smith SM; de Jager CA; Whitbread P; Johnston C; Agacinski G; Oulhaj A; Bradley KM; Jacoby R; Refsum H
    PLoS One; 2010 Sep; 5(9):e12244. PubMed ID: 20838622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower omega-3 fatty acid intake and status are associated with poorer cognitive function in older age: A comparison of individuals with and without cognitive impairment and Alzheimer's disease.
    Phillips MA; Childs CE; Calder PC; Rogers PJ
    Nutr Neurosci; 2012 Nov; 15(6):271-7. PubMed ID: 22824373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.
    Andrieu S; Guyonnet S; Coley N; Cantet C; Bonnefoy M; Bordes S; Bories L; Cufi MN; Dantoine T; Dartigues JF; Desclaux F; Gabelle A; Gasnier Y; Pesce A; Sudres K; Touchon J; Robert P; Rouaud O; Legrand P; Payoux P; Caubere JP; Weiner M; Carrié I; Ousset PJ; Vellas B;
    Lancet Neurol; 2017 May; 16(5):377-389. PubMed ID: 28359749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.
    Aisen PS; Schneider LS; Sano M; Diaz-Arrastia R; van Dyck CH; Weiner MF; Bottiglieri T; Jin S; Stokes KT; Thomas RG; Thal LJ;
    JAMA; 2008 Oct; 300(15):1774-83. PubMed ID: 18854539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine and Dementia: An International Consensus Statement.
    Smith AD; Refsum H; Bottiglieri T; Fenech M; Hooshmand B; McCaddon A; Miller JW; Rosenberg IH; Obeid R
    J Alzheimers Dis; 2018; 62(2):561-570. PubMed ID: 29480200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive effects of folic acid supplementation on cognitive aging are dependent on ω-3 fatty acid status: a post hoc analysis of the FACIT trial.
    van Soest APM; van de Rest O; Witkamp RF; de Groot LCPGM
    Am J Clin Nutr; 2021 Apr; 113(4):801-809. PubMed ID: 33564824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized placebo controlled trial of vitamin B
    Kwok T; Lee J; Ma RC; Wong SY; Kung K; Lam A; Ho CS; Lee V; Harrison J; Lam L
    Clin Nutr; 2017 Dec; 36(6):1509-1515. PubMed ID: 27823800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-Vitamin Intake and Biomarker Status in Relation to Cognitive Decline in Healthy Older Adults in a 4-Year Follow-Up Study.
    Hughes CF; Ward M; Tracey F; Hoey L; Molloy AM; Pentieva K; McNulty H
    Nutrients; 2017 Jan; 9(1):. PubMed ID: 28075382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.